Literature DB >> 12914895

A test of the tripartite model's prediction of anhedonia's specificity to depression: patients with major depression versus patients with schizophrenia.

Thomas E Joiner1, Jessica S Brown, Gerald I Metalsky.   

Abstract

The tripartite model of depression and anxiety suggests that anhedonia represents a relatively specific marker of depression. A strong version of this view is that anhedonic symptoms would particularly characterize depressed patients, even when compared to another diagnostic group-schizophrenic patients-for whom anhedonic symptoms represent a well-studied feature. This prediction was tested among 102 VA psychiatric inpatients (95 men), ages 21-72 (M=43.56; S.D.=8.47), all of whom received diagnoses of either major depression (n=50) or schizophrenia (n=52) based on structured diagnostic interviews. As predicted, patients with major depression scored significantly higher on the anhedonic symptoms scale of the Beck Depression Inventory (BDI) than did patients with schizophrenia. However, there was no difference between the two groups on the BDI total score or the BDI non-anhedonic symptoms score. Consistent with the tripartite model, anhedonic symptoms were more related to depressive vs. schizophrenic diagnostic status, whereas non-anhedonic depressive symptoms were not. Within the study's limitations, results were interpreted as relatively strong support for the validity and extension of the tripartite model.

Entities:  

Mesh:

Year:  2003        PMID: 12914895     DOI: 10.1016/s0165-1781(03)00131-8

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  40 in total

1.  A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence.

Authors:  Ruth S Barr; Diego A Pizzagalli; Melissa A Culhane; Donald C Goff; A Eden Evins
Journal:  Biol Psychiatry       Date:  2007-11-05       Impact factor: 13.382

2.  Phase relationships between core body temperature, melatonin, and sleep are associated with depression severity: further evidence for circadian misalignment in non-seasonal depression.

Authors:  Brant P Hasler; Daniel J Buysse; David J Kupfer; Anne Germain
Journal:  Psychiatry Res       Date:  2010-05-14       Impact factor: 3.222

3.  Anhedonia, Emotional Numbing, and Symptom Overreporting in Male Veterans with PTSD.

Authors:  Todd B Kashdan; Jon D Elhai; B Christopher Frueh
Journal:  Pers Individ Dif       Date:  2007-09

4.  Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.

Authors:  Elizabeth D Ballard; Kathleen Wills; Níall Lally; Erica M Richards; David A Luckenbaugh; Tessa Walls; Rezvan Ameli; Mark J Niciu; Nancy E Brutsche; Lawrence Park; Carlos A Zarate
Journal:  J Affect Disord       Date:  2017-04-25       Impact factor: 4.839

5.  Using a data science approach to predict cocaine use frequency from depressive symptoms.

Authors:  Robert Suchting; Jessica N Vincent; Scott D Lane; Charles E Green; Joy M Schmitz; Margaret C Wardle
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

6.  Reward dysfunction in major depression: multimodal neuroimaging evidence for refining the melancholic phenotype.

Authors:  Dan Foti; Joshua M Carlson; Colin L Sauder; Greg H Proudfit
Journal:  Neuroimage       Date:  2014-07-01       Impact factor: 6.556

7.  Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence.

Authors:  Paul Crits-Christoph; Steven Wadden; Averi Gaines; Agnes Rieger; Robert Gallop; James R McKay; Mary Beth Connolly Gibbons
Journal:  J Subst Abuse Treat       Date:  2018-06-21

8.  Common and Dissociable Dysfunction of the Reward System in Bipolar and Unipolar Depression.

Authors:  Theodore D Satterthwaite; Joseph W Kable; Lillie Vandekar; Natalie Katchmar; Danielle S Bassett; Claudia F Baldassano; Kosha Ruparel; Mark A Elliott; Yvette I Sheline; Ruben C Gur; Raquel E Gur; Christos Davatzikos; Ellen Leibenluft; Michael E Thase; Daniel H Wolf
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 9.  On the specificity of positive emotional dysfunction in psychopathology: evidence from the mood and anxiety disorders and schizophrenia/schizotypy.

Authors:  David Watson; Kristin Naragon-Gainey
Journal:  Clin Psychol Rev       Date:  2009-11-12

10.  Anhedonia in schizophrenia and major depression: state or trait?

Authors:  Lorenzo Pelizza; Alberto Ferrari
Journal:  Ann Gen Psychiatry       Date:  2009-10-08       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.